These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16523380)

  • 1. Advancing protein therapeutics: current challenges in protein therapeutics -- CHI's Second Annual Conference.
    He M
    IDrugs; 2006 Mar; 9(3):177-8. PubMed ID: 16523380
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein expression -- CHI's Ninth Annual Conference -- optimizing protein expression.
    Marchal-Gerez I
    IDrugs; 2006 Mar; 9(3):174-6. PubMed ID: 16523379
    [No Abstract]   [Full Text] [Related]  

  • 3. Commercial challenges of protein drug delivery.
    Brown LR
    Expert Opin Drug Deliv; 2005 Jan; 2(1):29-42. PubMed ID: 16296733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in engineering and delivery of protein and antibody therapeutics.
    Fernández LÁ; Muyldermans S
    Curr Opin Biotechnol; 2011 Dec; 22(6):839-42. PubMed ID: 21862312
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction to current and future protein therapeutics: a protein engineering perspective.
    Carter PJ
    Exp Cell Res; 2011 May; 317(9):1261-9. PubMed ID: 21371474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-based technologies for target discovery.
    Valle RP; Jendoubi M
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):197-203. PubMed ID: 12669455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of protein therapeutics.
    De Groot AS; Scott DW
    Trends Immunol; 2007 Nov; 28(11):482-90. PubMed ID: 17964218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of therapeutic protein in vivo activities through glycoengineering.
    Elliott S; Lorenzini T; Asher S; Aoki K; Brankow D; Buck L; Busse L; Chang D; Fuller J; Grant J; Hernday N; Hokum M; Hu S; Knudten A; Levin N; Komorowski R; Martin F; Navarro R; Osslund T; Rogers G; Rogers N; Trail G; Egrie J
    Nat Biotechnol; 2003 Apr; 21(4):414-21. PubMed ID: 12612588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein engineering for therapeutics, part B. Preface.
    Wittrup KD; Verdine GL
    Methods Enzymol; 2012; 503():xiii-xiv. PubMed ID: 22230575
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in protein therapeutics.
    Woodnutt G; Violand B; North M
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):754-61. PubMed ID: 18946840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Antibody Protein Therapeutics Development & Production--IBC Conference. Successful strategies for bringing protein therapeutics to market.
    Thorne B
    IDrugs; 2009 May; 12(5):271-4. PubMed ID: 19431086
    [No Abstract]   [Full Text] [Related]  

  • 15. Biopharmaceutical proteins: opportunities and challenges.
    Birch JR; Onakunle Y
    Methods Mol Biol; 2005; 308():1-16. PubMed ID: 16082021
    [No Abstract]   [Full Text] [Related]  

  • 16. Engineering antibodies for the 21st century.
    Huston JS
    Protein Eng Des Sel; 2012 Oct; 25(10):483-4. PubMed ID: 22988131
    [No Abstract]   [Full Text] [Related]  

  • 17. Advancing mammalian cell culture engineering using genome-scale technologies.
    Griffin TJ; Seth G; Xie H; Bandhakavi S; Hu WS
    Trends Biotechnol; 2007 Sep; 25(9):401-8. PubMed ID: 17681628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic advances in rheumatology with the use of recombinant proteins.
    Rothe A; Power BE; Hudson PJ
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant therapeutic proteins: production platforms and challenges.
    Dingermann T
    Biotechnol J; 2008 Jan; 3(1):90-7. PubMed ID: 18041103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered antibody therapeutics.
    Mather JP
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):631-2. PubMed ID: 16857292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.